5 Dec 2025
Five year follow-up of belzutifan for VHL disease
5 Dec 2025
Five-year follow-up results of adjuvant pembrolizumab for kidney cancer
5 Dec 2025
Avelumab plus axitinib approved for use on the NHS in England and Wales
3 Dec 2025
Patient guide on immune-related side effects and their management
3 Dec 2025
UK-US trade deal for medicines
28 Nov 2025
Neoadjuvant therapy helps partial nephrectomy for kidney cancer
21 Nov 2025
Stopping treatment with immunotherapy after immune-related side effects seems to have favourable outcomes
21 Nov 2025
The role of nutrition in kidney cancer care
17 Nov 2025
High-Fibre diet may boost immunotherapy activity in advanced kidney cancer patients
17 Nov 2025
'Helpful in so many ways': Guildford Kidney Cancer Patient Information Day
28 Oct 2025
Belzutifan plus lenvatinib show promise as a second-line treatment for advanced kidney cancer
28 Oct 2025
Pembrolizumab plus belzutifan combination shows promise as an adjuvant treatment for kidney cancer
